Check out the Detailed Program! Learn More

Endosonography for Staging Esophageal Tumors

Accurate staging is central to choosing treatment for oesophageal cancer. Endoscopic ultrasonography, commonly called EUS or endosonography, provides high-resolution images of the oesophageal wall and nearby lymph nodes, helping clinicians define local tumour invasion and assess regional spread.

For Australian teams, EUS findings sit within a broader pathway that may include gastroscopy, contrast-enhanced CT, FDG-PET/CT, pathology and multidisciplinary review. A patient in Sydney or Melbourne may move quickly through a tertiary cancer service, while someone in regional Queensland, Western Australia or the Northern Territory may need coordinated travel and telehealth support.

What Endosonography Shows

The oesophageal wall has recognisable ultrasound layers, allowing EUS to estimate how deeply a tumour has penetrated. This is particularly useful for distinguishing early disease confined to the mucosa or submucosa from lesions invading the muscularis propria or surrounding tissue.

EUS is strongest for local T staging. It can identify suspicious lymph nodes based on size, shape, borders and echogenicity, although appearance alone is imperfect. Fine-needle aspiration or fine-needle biopsy can add tissue confirmation, especially when a positive nodal result would change the treatment plan.

Selecting Patients And Timing

EUS is most valuable when local staging will influence management. Early lesions being considered for endoscopic resection require careful assessment of depth, ulceration and possible lymphovascular risk. For locally advanced disease, EUS can help establish a baseline before neoadjuvant chemotherapy or chemoradiotherapy.

It should generally be interpreted alongside CT and PET/CT rather than used in isolation. CT is useful for distant anatomy and complications, while PET/CT can reveal metabolically active disease beyond the regional field. In Australia, these results are commonly reviewed at a multidisciplinary meeting involving gastroenterology, radiology, surgery, medical oncology and radiation oncology.

Practical Techniques That Improve Accuracy

A complete examination begins with careful review of the diagnostic gastroscopy, tumour location and biopsy results. The endosonographer should document the upper and lower tumour margins, distance from the incisors, relationship to the gastro-oesophageal junction and any stenosis that limits scope passage.

Water coupling and appropriate frequency selection improve contact and image quality. Radial EUS is useful for circumferential anatomical assessment, while linear EUS enables targeted sampling. When a node is sampled, the needle path should avoid traversing the primary tumour where feasible, reducing the risk of contamination and ensuring that the specimen answers the clinical question.

Common Pitfalls In Tumour Staging

Inflammation, fibrosis, ulceration and treatment-related oedema can mimic malignant invasion. A bulky lesion may obscure the deeper wall layers, leading to over-staging, while microscopic extension beyond an apparently intact layer can be missed. Benign reactive nodes may appear suspicious, and small malignant nodes may look deceptively ordinary.

Strictures are another practical problem. Forceful passage risks perforation and may produce incomplete staging. In a patient with significant narrowing, staging may need to rely more heavily on cross-sectional imaging, or be repeated after initial treatment. Operator experience matters, and reports should state technical limitations clearly rather than presenting uncertain findings as definitive.

Sampling also has limitations. FNA or FNB can be non-diagnostic because of fibrosis, necrosis, scant cellularity or difficult access. A negative sample does not always exclude malignancy when the ultrasound pattern and clinical context remain concerning. If a treatment reaction creates an unrelated skin differential, a clinical reference resource may help support broader documentation, though it does not replace pathology or specialist review.

Integrating Results Into Care

EUS staging should answer a practical question: will this result alter the next treatment decision? A suspicious regional node confirmed by biopsy may support neoadjuvant therapy, whereas a superficial lesion without high-risk features may be considered for endoscopic treatment. The final plan must account for histology, patient fitness, nutrition, symptoms and comorbidities.

Nutrition is especially important in Australian practice, where patients may be referred between public hospitals, private specialists and rural services. Dysphagia, weight loss and dehydration can delay therapy, so staging should be coordinated with dietitians and supportive-care teams. Emerging approaches, including localised treatment strategies, are discussed in research coverage of novel drug delivery, but these concepts remain distinct from routine EUS staging.

Clear reporting should include the tumour site, estimated T category, regional nodal findings, sampled targets, technical restrictions and confidence level. It should also identify features relevant to resectability, such as invasion of adjacent structures, while recognising that CT, PET/CT and operative assessment may revise the initial impression.

The key point to remember is that endosonography is a high-value local staging tool, not a standalone verdict: its accuracy depends on technique, tissue confirmation when needed, awareness of pitfalls and integration with the full multidisciplinary picture.

About ISDE

The ISDE is an international, multispecialty society devoted to the study of the esophagus in disease and in health that was founded in 1979. The aims of the ISDE are to promote the exchange of scientific and medical knowledge among specialists in the field, to maintain interchange with organizations and industries, and to encourage basic and clinical research in fields related to the esophagus. In order to promote the professional and educational development of individuals interested in the esophagus, the ISDE sponsors its own journal, international congresses, and other educational programs. The ISDE Secretariat was in Tokyo, Japan, from 1979 to 2004, and then resided in Los Angeles, California, from 2004 through 2010. Since 2010 the Secretariat has been in Vancouver, British Columbia, under the auspices of International Conferences Service, Ltd. The ISDE welcomes participation by existing members and encourages individuals who are professionally interested in the esophagus to become members. Benefits include reduced registration fees at our congresses and other educational offerings, restricted access to website content and member search capability, access to webcasts, reduced subscription rates for our journal, and the opportunity to help lead this organization into a position of leadership in the worldwide medical community.